Debunking Drug Claims in Dr. Bronner’s Coconut Oil
August 15th, 2014
The FDA doesn’t comment on that last particular use of Dr. Bronner’s Magic “All-One!” Fresh-Pressed Virgin Coconut Oil product (take a breath), but rather addresses the apparent misbranding in a recent warning letter to CEO David Bronner.
The July letter stated that the promotion of the product as a drug violates the federal Food, Drug and Cosmetic Act because the FDA has not approved it as such. The FDA cites the following claim as evidence that the product is illegally being marketed as a drug:
Clinical research confirms that the saturated medium chain fatty acids (MTC’s) in [Virgin Coconut Oil], such as lauric acid, actually improve blood cholesterol by increasing the ratio of HDL to LDL cholesterol.
The claim that the product can improve blood cholesterol “implies that (the) product is intended for use in the treatment, mitigation, and prevention of coronary heart disease,” and thus qualifies it as a drug, the FDA said.
For more of our coverage on the marketing of drugs, click here.